Le 15 octobre 2026, l\u2019Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM) organise \u00e0 Paris le \u00ab IncreaseNET x EU Innovation Network 2026 Innovation & Competitiveness Summit \u00bb, qui r\u00e9unit pr\u00e8s d\u2019une centaine de participants. Sont attendus des repr\u00e9sentants d\u2019autorit\u00e9s nationales et europ\u00e9ennes, des acteurs de la recherche clinique, des repr\u00e9sentants acad\u00e9miques, des petites et moyennes entreprises (PME) et des structures de financement de la recherche. L\u2019\u00e9v\u00e9nement est coorganis\u00e9 par la joint action europ\u00e9enne IncreaseNET et le r\u00e9seau EU Innovation Network (EU-IN), groupe de travail conjoint de l\u2019Agence europ\u00e9enne du m\u00e9dicament (EMA) et du r\u00e9seau des directeurs des agences nationales du m\u00e9dicament (HMA \u2013 Heads of Medicines Agencies).<\/p>\n
IncreaseNET est une action conjointe financ\u00e9e par la Commission europ\u00e9enne et pilot\u00e9e par l\u2019agence slov\u00e8ne des m\u00e9dicaments et des dispositifs m\u00e9dicaux (JAZMP). Elle vise \u00e0 renforcer l\u2019expertise et les comp\u00e9tences r\u00e9glementaires au sein du r\u00e9seau europ\u00e9en de r\u00e9glementation des m\u00e9dicaments (EMRN) afin de mieux r\u00e9pondre aux enjeux li\u00e9s \u00e0 l\u2019innovation en sant\u00e9. Dans ce cadre, l\u2019ANSM coordonne un groupe de travail d\u00e9di\u00e9 \u00e0 l\u2019accompagnement de l\u2019innovation, ayant pour objectif d\u2019harmoniser les pratiques de soutien \u00e0 l\u2019innovation entre agences europ\u00e9ennes et de favoriser une approche plus coordonn\u00e9e \u00e0 l\u2019\u00e9chelle du r\u00e9seau.<\/p>\n
Plusieurs actions concr\u00e8tes sont en cours : organisation de formations sur des th\u00e9matiques \u00e9mergentes (par exemple technologies \u00e0 ARN, organes sur puce), \u00e9laboration d\u2019une \u00ab bo\u00eete \u00e0 outils \u00bb pour aider les agences \u00e0 cr\u00e9er ou d\u00e9velopper leur guichet innovation, et travaux pour rendre plus lisible l\u2019offre europ\u00e9enne d\u2019accompagnement \u00e0 destination des porteurs de projet. L\u2019engagement de l\u2019ANSM dans IncreaseNET s\u2019appuie sur l\u2019exp\u00e9rience de son guichet innovation et orientation (GIO), qui constitue un point d\u2019entr\u00e9e pour les porteurs de projet universitaires et les PME, avec un accompagnement adapt\u00e9 \u00e0 leurs besoins.<\/p>\n
La journ\u00e9e du 15 octobre est pr\u00e9sent\u00e9e comme un temps d\u2019\u00e9changes sur les leviers permettant de renforcer l\u2019attractivit\u00e9 et la comp\u00e9titivit\u00e9 de l\u2019Europe en mati\u00e8re d\u2019innovation en sant\u00e9, notamment par un accompagnement plus accessible et mieux coordonn\u00e9. Les discussions portent en particulier sur la comp\u00e9titivit\u00e9 europ\u00e9enne et l\u2019\u00e9volution du cadre r\u00e9glementaire, l\u2019organisation et le financement de la recherche clinique en France, la coordination et la compl\u00e9mentarit\u00e9 entre le r\u00e9seau europ\u00e9en et les dispositifs nationaux et europ\u00e9ens d\u2019accompagnement \u00e0 l\u2019innovation des PME et du monde universitaire, ainsi que sur la diversit\u00e9 des dispositifs de soutien existants (avis scientifiques nationaux et europ\u00e9ens, accompagnement par les bureaux d\u2019innovation). Des informations compl\u00e9mentaires sur IncreaseNET et le r\u00e9seau EU Innovation Network sont accessibles en ligne, ainsi qu\u2019un programme d\u00e9taill\u00e9 et un acc\u00e8s \u00e0 distance \u00e0 l\u2019\u00e9v\u00e9nement.\u00a0(contenu r\u00e9sum\u00e9 par l’IA)Lire la Suite<\/a>\u200b<\/p>","protected":false},"excerpt":{"rendered":" Le 15 octobre 2026, l\u2019Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM) organise \u00e0 Paris le \u00ab IncreaseNET x EU Innovation Network 2026 Innovation & Competitiveness […]<\/p>\n","protected":false},"author":1,"featured_media":3852,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[7],"tags":[63,227],"class_list":["post-20874","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicaments-et-produits-de-sante","tag-ansm","tag-ia"],"_links":{"self":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/20874","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=20874"}],"version-history":[{"count":0,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/20874\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/media\/3852"}],"wp:attachment":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=20874"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=20874"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=20874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}